CAPTRUST Financial Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $198K | Buy |
22,105
+1,527
| +7% | +$13.7K | ﹤0.01% | 2309 |
|
|
2025
Q1 | $154K | Buy |
20,578
+4,080
| +25% | +$30.6K | ﹤0.01% | 2198 |
|
|
2024
Q4 | $124K | Buy |
16,498
+224
| +1% | +$1.68K | ﹤0.01% | 2188 |
|
|
2024
Q3 | $124K | Buy |
16,274
+2,644
| +19% | +$20.1K | ﹤0.01% | 2190 |
|
|
2024
Q2 | $84.2K | Buy |
13,630
+345
| +3% | +$2.13K | ﹤0.01% | 2120 |
|
|
2024
Q1 | $67.5K | Buy |
+13,285
| New | +$67.5K | ﹤0.01% | 2073 |
|
|
2022
Q3 | – | Sell |
-6,421
| Closed | -$68K | – | 2262 |
|
|
2022
Q2 | $68K | Sell |
6,421
-166
| -3% | -$1.76K | ﹤0.01% | 2507 |
|
|
2022
Q1 | $107K | Buy |
6,587
+341
| +5% | +$5.54K | ﹤0.01% | 2211 |
|
|
2021
Q4 | $87K | Sell |
6,246
-1,571
| -20% | -$21.9K | ﹤0.01% | 2261 |
|
|
2021
Q3 | $112K | Buy |
7,817
+2,624
| +51% | +$37.6K | ﹤0.01% | 1982 |
|
|
2021
Q2 | $82K | Hold |
5,193
| – | – | ﹤0.01% | 2174 |
|
|
2021
Q1 | $53K | Sell |
5,193
-657
| -11% | -$6.71K | ﹤0.01% | 2394 |
|
|
2020
Q4 | $44K | Sell |
5,850
-1,250
| -18% | -$9.4K | ﹤0.01% | 1885 |
|
|
2020
Q3 | $25K | Buy |
7,100
+3,628
| +104% | +$12.8K | ﹤0.01% | 1875 |
|
|
2020
Q2 | $17K | Buy |
+3,472
| New | +$17K | ﹤0.01% | 2002 |
|